Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
FEIBA in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre
Haemophilia, 03/19/09
Smejkal P et al. - The cumulative dose of FEIBA was lower for three episodes with re-bleeding: median 96 U/kg but not in the two cases of ineffective treatment: 361 U/kg. FEIBA® in management of bleeding episodes completely resolved the haemorrhage in 91.8% of events and in a further 4.9% if treatment was restarted. Using home treatment saved expenditure due to the lower cumulative dose needed for treatment of haemorrhage.
Related Articles
The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery
Haemophilia, 11/25/09
Relevance Score: 67%%
Development and preliminary testing of a Paediatric Version of the Haemophilia Activities List (pedhal)
Haemophilia, 11/18/09
Relevance Score: 67%%
Malignancy in patients with haemophilia: a review of the literature
Haemophilia, 11/16/09
Relevance Score: 67%%
Postmarketing surveillance study of KOGENATE Bayer with Bio-Set in patients with haemophilia A: evaluation of patients' satisfaction after switch to the new reconstitution system
Haemophilia, 11/05/09
Relevance Score: 67%%
Physical activity levels and participation in sport in Irish people with haemophilia
Haemophilia, 11/04/09
Relevance Score: 66%%
Today in HemeOnc Emergencies...keeping you current
Receive free subspecialty "5-minute updates" via email
Predicting the complicated neutropenic fever in the emergency department
Emergency Medicine Journal, 12/02/09
Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study
Critical Reviews in Oncology/Hematology, 12/02/09
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
International Journal of Emergency Medicine, 12/01/09
Sponsor
Article Search
Sponsor


See Latest Articles


